| Dr Atizazul H Mansoor, MD | |
|
2808 Old Post Rd, Harrisburg, PA 17110-3685 | |
| (717) 980-4400 | |
| Not Available |
| Full Name | Dr Atizazul H Mansoor |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 18 Years |
| Location | 2808 Old Post Rd, Harrisburg, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1871719377 | NPI | - | NPPES |
| 102844190 | Medicaid | PA |
| Facility Name | Location | Facility Type |
|---|---|---|
| Pinnacle Health Hospitals | Harrisburg, PA | Hospital |
| Waynesboro Hospital | Waynesboro, PA | Hospital |
| Carlisle Regional Medical Center | Carlisle, PA | Hospital |
| Chambersburg Hospital | Chambersburg, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Pinnacle Health Cardiovascular Institute Inc | 6901087006 | 105 |
News Archive
Experimental Alzheimer's drugs have shown little success in slowing declines in memory and thinking, leaving scientists searching for explanations.
Several months into the COVID-19 pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), we still do not know much about the early evolutionary history and order of mutational events of the virus during this pandemic.
A major challenge in the field of neurodegeneration is the unclear understanding of neuronal dysfunction. Elucidation of these patho-mechanisms could result in the identification of novel therapeutic targets. In this article, Bell et al. present an exhaustive literature review highlighting the endoplasmic reticulum (ER) kinase PERK as a crucial contributor to systemic and neurodegenerative disorders.
A new study shows that fibromyalgia patients who stopped taking medication but exercised regularly for six weeks reported improved memory function and less pain. While the finding is encouraging, it does not suggest a potential change in clinical care for fibromyalgia patients, the study authors stressed.
Abraxis BioScience, Inc., a fully integrated biotechnology company, previously announced it will be presenting more than 30 studies, including new clinical data evaluating the use of nanoparticle albumin bound driven chemotherapy, nab-paclitaxel (ABRAXANE for Injectable suspension; paclitaxel protein albumin-bound particles for injectable suspension) for the treatment of pancreatic cancer at the 46th Annual Meeting of the American Society of Clinical Oncology in Chicago.
› Verified 6 days ago
| Entity Name | Pinnacle Health Cardiovascular Institute Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952603342 PECOS PAC ID: 6901087006 Enrollment ID: O20110223000139 |
News Archive
Experimental Alzheimer's drugs have shown little success in slowing declines in memory and thinking, leaving scientists searching for explanations.
Several months into the COVID-19 pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), we still do not know much about the early evolutionary history and order of mutational events of the virus during this pandemic.
A major challenge in the field of neurodegeneration is the unclear understanding of neuronal dysfunction. Elucidation of these patho-mechanisms could result in the identification of novel therapeutic targets. In this article, Bell et al. present an exhaustive literature review highlighting the endoplasmic reticulum (ER) kinase PERK as a crucial contributor to systemic and neurodegenerative disorders.
A new study shows that fibromyalgia patients who stopped taking medication but exercised regularly for six weeks reported improved memory function and less pain. While the finding is encouraging, it does not suggest a potential change in clinical care for fibromyalgia patients, the study authors stressed.
Abraxis BioScience, Inc., a fully integrated biotechnology company, previously announced it will be presenting more than 30 studies, including new clinical data evaluating the use of nanoparticle albumin bound driven chemotherapy, nab-paclitaxel (ABRAXANE for Injectable suspension; paclitaxel protein albumin-bound particles for injectable suspension) for the treatment of pancreatic cancer at the 46th Annual Meeting of the American Society of Clinical Oncology in Chicago.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Atizazul H Mansoor, MD 409 S 2nd St, Suite 2f, Harrisburg, PA 17104-1612 Ph: (717) 920-4400 | Dr Atizazul H Mansoor, MD 2808 Old Post Rd, Harrisburg, PA 17110-3685 Ph: (717) 980-4400 |
News Archive
Experimental Alzheimer's drugs have shown little success in slowing declines in memory and thinking, leaving scientists searching for explanations.
Several months into the COVID-19 pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), we still do not know much about the early evolutionary history and order of mutational events of the virus during this pandemic.
A major challenge in the field of neurodegeneration is the unclear understanding of neuronal dysfunction. Elucidation of these patho-mechanisms could result in the identification of novel therapeutic targets. In this article, Bell et al. present an exhaustive literature review highlighting the endoplasmic reticulum (ER) kinase PERK as a crucial contributor to systemic and neurodegenerative disorders.
A new study shows that fibromyalgia patients who stopped taking medication but exercised regularly for six weeks reported improved memory function and less pain. While the finding is encouraging, it does not suggest a potential change in clinical care for fibromyalgia patients, the study authors stressed.
Abraxis BioScience, Inc., a fully integrated biotechnology company, previously announced it will be presenting more than 30 studies, including new clinical data evaluating the use of nanoparticle albumin bound driven chemotherapy, nab-paclitaxel (ABRAXANE for Injectable suspension; paclitaxel protein albumin-bound particles for injectable suspension) for the treatment of pancreatic cancer at the 46th Annual Meeting of the American Society of Clinical Oncology in Chicago.
› Verified 6 days ago
Lindsey Marie Govern, DO Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 810 Sir Thomas Ct Ste 101, Harrisburg, PA 17109 Phone: 717-614-4420 Fax: 717-614-4421 | |
Quan Tran, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 111 S Front St, Harrisburg, PA 17101 Phone: 717-231-8772 | |
Richard Haley Jeffries, DO Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 4830 Londonderry Rd, Harrisburg, PA 17109 Phone: 717-657-2595 Fax: 717-657-3091 | |
Joanne G Gordon, MD Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 111 S Front St, Harrisburg, PA 17101 Phone: 717-782-3380 Fax: 717-782-5716 | |
Dr. David Edward Dudick, M.D. Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 111 S Front St, Internal Medicine Residency Program, Brady Hall 3, Harrisburg, PA 17101 Phone: 717-782-3131 | |
Emily Ramasra, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 111 S Front St, Harrisburg, PA 17101 Phone: 717-231-8506 | |
Mr. Siddharth Goel, M.D. Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 205 S Front St Upmc Pinnacle, Internal Medicine Residen, Suite 3c, Harrisburg, PA 17104 Phone: 717-231-8506 Fax: 717-231-8535 |